Tumor stimulator cell modification by infection with Newcastle Disease Virus: analysis of effects and mechanism in MLTC-CML cultures
/in International Publications, Newcastle Disease Virus /von 1999-02-01 / Int. J. Oncol. 1999 Feb;14(2):205-15[Hyperthermia in combination with chemotherapy in gynecological cancers]
/in Hyperthermia, International Publications /von 1999-01-09 / Ned Tijdschr Geneeskd 1999 Jan;143(2):85-8A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees C whole-body hyperthermia
/in Hyperthermia, International Publications /von 1999-01-01 / Cancer Chemother. Pharmacol. 1999;43(5):409-14Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus
/in International Publications, Newcastle Disease Virus /von 1999-01-01 / Gene Ther. 1999 Jan;6(1):63-73Characterization of mild whole-body hyperthermia protocols using human breast, ovarian, and colon tumors grown in severe combined immunodeficient mice
/in Colorectal Cancer, Hyperthermia, International Publications /von 1999-01-01 / Infect Dis Obstet Gynecol 1999;7(1-2):91-7Introduction of adhesive and costimulatory immune functions into tumor cells by infection with Newcastle Disease Virus
/in International Publications, Newcastle Disease Virus /von 1998-12-01 / Int. J. Oncol. 1998 Dec;13(6):1105-15A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire
/in International Publications, Malignant Melanoma, Newcastle Disease Virus /von 1998-12-01 / Mol. Med. 1998 Dec;4(12):783-94Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice
/in Chronic Virus Hepatitis, International Publications /von 1998-11-01 / J. Immunol. 1998 Nov;161(9):4520-9[Current methods of radiation therapy in patients with prostatic cancer: subtotal body radiation, local hyperthermia]
/in Hyperthermia, International Publications, Prostate Cancer /von 1998-09-01 / Vestn Rentgenol Radiol 1998 Sep-Oct;(5):30-3IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de